SUMMARY The in vitro sensitivity of 104 isolates ofNeisseria gonorrhoeae to six antimicrobial agents was tested. More than 50% ofthe isolates produced penicillinase. Ofthose that did not produce penicillinase, 26% were resistant (minimum inhibitory concentration (MIC)) > 0 5 mg/i), and 68% showed a decreased sentitivity for penicillin G (0-06 < MIC < 0-25 mg/i). Twenty six per cent and 50% ofthe strains, respectively, showed a decreased sensitivity to thiamphenicol (MIC > 1 mg/i) and tetracycline (MIC > 2 mg/i). All isolates were sensitive to spectinomycin, kanamycin, and norfloxacin. Of 20 penicillinase producing N gonorrhoeae (PPNG) isolates examined, seven contained the 3-4 megadalton R-plasmid, another seven contained both the 3-4 megadalton and 22 5 megadalton plasmids, five the 4-3 megadalton and 22 5 megadalton plasmids, and one isolate harboured both the 34 and 43 R-plasmids, together with the 22-5 megadalton plasmid. A disturbing increase in resistance to penicillin has been observed since the publication of earlier surveys, and the clinical implications of these findings are discussed.
In vitro antimicrobial sensitivity ofNeisseria gonorrhoeae from Rwanda Second and third generation cephalosporins should not be used in developing areas with high sexual promiscuity, irrespective ofthe cost ofthe treatment, in view of the risk of the emergence of increasingly resistant strains. Their use should be restricted, therefore, to the inpatient treatment of serious infections with multiresistant Gram negative micro-organisms, which are extremely common in the tropics.
Though we cannot rule out the presence of strains resistant to spectinomycin in Rwanda, we believe that their prevalance is very low and that this drug is the best alternative for treating uncomplicated gonorrhoea. A list ofless expensive, but also less effective, drugs was developed by the WHO experts. It includes: kanamycin (2 g) by intramuscular injection, thiamphenicol (2 5 g) in a single oral dose, and cotrimoxazole (trimethoprim (80 mg) sulphamethoxazole (400 mg) 10 tablets taken once daily for three days. As multiple dose treatments are not indicated for developing countries (due to the considerable risk that the drug may be put aside for later use or sold to other patients), co-trimoxazole has no place in the treatment of gonorrhoea.
Our in vitro results indicate that kanamycin is a suitable alternative for spectinomycin. It is effective in the treatment of both PPNG and non-PPNG strains,9 10 but this drug is too expensive for the first line treatment of gonorrhoea. Furthermore, no information exists on the toxicity of this dose. A failure rate of 12 5% was observed in Thailand," but 30% of the local strains had a MIC of > 32 mg/l kanamycin.'2 In Singapore 22% of the isolates showed a MIC of 32 mg/i kanamycin'3 with a therapeutic failure rate of 11%. '4 Thiamphenicol is cheap, can be given as a single oral dose, and shows no important side effects, though its potential for irreversible haematotoxic damage is still debatable. Treatment failures have been correlated with MICs of > 1 mg/i.'5 16 Thus infections with strains havng a MIC of 2 mg/l failed to respond in 4.5%15 and 14.3%16 of patients when treated with a 2-5 g single oral dose. The newer quinolones seem to be the most promising agents in the treatment of gonorrhoea. Their in vitro activity is extremely high 1719 and the peak serum concentrations largely exceed the observed MICs.20 More information, however, is needed on their clinical efficacy, absence of serious side effects, and cost of the treatment.
Our results confirm that both types of R-plasmidsthe "Asian" and the "African" types -are now occurring among PPNG strains in Africa, as previously reported from Kenya.2' Moreover, half of the isolates harbouring the 3 4 megadalton plasmid are also carrying the longer transfer factor, in contrast to the earlier PPNG isolates originally described from Africa.2223 This acquisition of the transfer plasmid may explain the dramatic increase in the proportion of PPNG strains in Africa in recent years. To the best of our knowledge the concomitant occurrence ofboth the 3A4 and 4'3 megadalton plasmids in the same isolate has not been reported before, and it further illustrates the potential for exchange of plasmids among Ngonorrhoeae strains.
We can speculate that PPNG strains were imported from neighbouring Kenya, a country that has extensive commercial relations with Rwanda, and where the first PPNG strains were isolated in June 1981.21
Continuous monitoring of microbial sensitivity is imperative for optimal therapeutic regimens to be selected.
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